nodes	percent_of_prediction	percent_of_DWPC	metapath
Apixaban—ABCG2—hematologic cancer	0.174	0.706	CbGaD
Apixaban—ABCB1—hematologic cancer	0.0723	0.294	CbGaD
Apixaban—ABCG2—Clofarabine—hematologic cancer	0.0264	0.0501	CbGbCtD
Apixaban—CYP1A2—Anagrelide—hematologic cancer	0.0157	0.0298	CbGbCtD
Apixaban—ABCG2—Daunorubicin—hematologic cancer	0.0155	0.0293	CbGbCtD
Apixaban—ABCG2—Teniposide—hematologic cancer	0.0135	0.0255	CbGbCtD
Apixaban—ABCG2—Cladribine—hematologic cancer	0.0129	0.0244	CbGbCtD
Apixaban—ABCG2—Imatinib—hematologic cancer	0.0119	0.0225	CbGbCtD
Apixaban—ABCG2—Nilotinib—hematologic cancer	0.0108	0.0204	CbGbCtD
Apixaban—CYP2C9—Bexarotene—hematologic cancer	0.00983	0.0186	CbGbCtD
Apixaban—ABCG2—Dasatinib—hematologic cancer	0.00954	0.0181	CbGbCtD
Apixaban—ABCB1—Lenalidomide—hematologic cancer	0.00954	0.018	CbGbCtD
Apixaban—ABCG2—Mitoxantrone—hematologic cancer	0.00942	0.0178	CbGbCtD
Apixaban—CYP2C8—Bortezomib—hematologic cancer	0.00864	0.0163	CbGbCtD
Apixaban—CYP3A5—Daunorubicin—hematologic cancer	0.00859	0.0163	CbGbCtD
Apixaban—CYP1A2—Carmustine—hematologic cancer	0.00827	0.0156	CbGbCtD
Apixaban—CYP2C9—Idarubicin—hematologic cancer	0.00814	0.0154	CbGbCtD
Apixaban—CYP3A5—Thalidomide—hematologic cancer	0.00782	0.0148	CbGbCtD
Apixaban—CYP3A5—Teniposide—hematologic cancer	0.00746	0.0141	CbGbCtD
Apixaban—ABCG2—Irinotecan—hematologic cancer	0.00742	0.014	CbGbCtD
Apixaban—CYP2C19—Bortezomib—hematologic cancer	0.00724	0.0137	CbGbCtD
Apixaban—CYP1A2—Methoxsalen—hematologic cancer	0.00703	0.0133	CbGbCtD
Apixaban—CYP3A5—Ifosfamide—hematologic cancer	0.00689	0.013	CbGbCtD
Apixaban—CYP1A2—Bortezomib—hematologic cancer	0.00668	0.0127	CbGbCtD
Apixaban—CYP2C8—Ifosfamide—hematologic cancer	0.00662	0.0125	CbGbCtD
Apixaban—CYP3A5—Imatinib—hematologic cancer	0.00658	0.0125	CbGbCtD
Apixaban—ABCG2—Vincristine—hematologic cancer	0.00648	0.0123	CbGbCtD
Apixaban—CYP1A2—Daunorubicin—hematologic cancer	0.00639	0.0121	CbGbCtD
Apixaban—CYP2C19—Thalidomide—hematologic cancer	0.00631	0.0119	CbGbCtD
Apixaban—CYP1A2—Alitretinoin—hematologic cancer	0.00626	0.0119	CbGbCtD
Apixaban—ABCG2—Cisplatin—hematologic cancer	0.00605	0.0114	CbGbCtD
Apixaban—CYP2C9—Bortezomib—hematologic cancer	0.00602	0.0114	CbGbCtD
Apixaban—CYP2C19—Teniposide—hematologic cancer	0.00602	0.0114	CbGbCtD
Apixaban—ABCG2—Etoposide—hematologic cancer	0.00594	0.0112	CbGbCtD
Apixaban—CYP1A2—Thalidomide—hematologic cancer	0.00582	0.011	CbGbCtD
Apixaban—CYP2C8—Nilotinib—hematologic cancer	0.00575	0.0109	CbGbCtD
Apixaban—CYP3A4—Bexarotene—hematologic cancer	0.00571	0.0108	CbGbCtD
Apixaban—ABCB1—Daunorubicin—hematologic cancer	0.00559	0.0106	CbGbCtD
Apixaban—CYP2C19—Ifosfamide—hematologic cancer	0.00556	0.0105	CbGbCtD
Apixaban—ABCB1—Alitretinoin—hematologic cancer	0.00548	0.0104	CbGbCtD
Apixaban—CYP3A4—Busulfan—hematologic cancer	0.00531	0.0101	CbGbCtD
Apixaban—CYP3A4—Lomustine—hematologic cancer	0.00531	0.0101	CbGbCtD
Apixaban—CYP2C19—Imatinib—hematologic cancer	0.00531	0.01	CbGbCtD
Apixaban—CYP3A5—Dasatinib—hematologic cancer	0.00528	0.01	CbGbCtD
Apixaban—CYP2C9—Thalidomide—hematologic cancer	0.00525	0.00993	CbGbCtD
Apixaban—CYP1A2—Dacarbazine—hematologic cancer	0.00501	0.00948	CbGbCtD
Apixaban—CYP2C9—Teniposide—hematologic cancer	0.00501	0.00947	CbGbCtD
Apixaban—CYP1A2—Imatinib—hematologic cancer	0.0049	0.00927	CbGbCtD
Apixaban—ABCG2—Dexamethasone—hematologic cancer	0.00489	0.00925	CbGbCtD
Apixaban—CYP3A4—Thiotepa—hematologic cancer	0.00473	0.00896	CbGbCtD
Apixaban—CYP2C9—Ifosfamide—hematologic cancer	0.00462	0.00874	CbGbCtD
Apixaban—CYP2C9—Imatinib—hematologic cancer	0.00441	0.00835	CbGbCtD
Apixaban—ABCB1—Imatinib—hematologic cancer	0.00428	0.0081	CbGbCtD
Apixaban—CYP3A5—Irinotecan—hematologic cancer	0.00411	0.00778	CbGbCtD
Apixaban—ABCG2—Doxorubicin—hematologic cancer	0.00405	0.00767	CbGbCtD
Apixaban—CYP2C9—Nilotinib—hematologic cancer	0.00401	0.00759	CbGbCtD
Apixaban—CYP1A2—Dasatinib—hematologic cancer	0.00393	0.00744	CbGbCtD
Apixaban—ABCG2—Methotrexate—hematologic cancer	0.00393	0.00743	CbGbCtD
Apixaban—ABCB1—Nilotinib—hematologic cancer	0.00389	0.00737	CbGbCtD
Apixaban—ABCB1—Vinorelbine—hematologic cancer	0.00386	0.0073	CbGbCtD
Apixaban—CYP3A4—Methoxsalen—hematologic cancer	0.00368	0.00697	CbGbCtD
Apixaban—CYP3A5—Vincristine—hematologic cancer	0.00359	0.0068	CbGbCtD
Apixaban—CYP3A4—Bortezomib—hematologic cancer	0.0035	0.00663	CbGbCtD
Apixaban—CYP2C19—Prednisone—hematologic cancer	0.0035	0.00662	CbGbCtD
Apixaban—ABCB1—Dasatinib—hematologic cancer	0.00344	0.00651	CbGbCtD
Apixaban—ABCB1—Mitoxantrone—hematologic cancer	0.0034	0.00643	CbGbCtD
Apixaban—CYP3A4—Daunorubicin—hematologic cancer	0.00335	0.00634	CbGbCtD
Apixaban—CYP3A5—Etoposide—hematologic cancer	0.00329	0.00623	CbGbCtD
Apixaban—CYP2C8—Etoposide—hematologic cancer	0.00317	0.00599	CbGbCtD
Apixaban—ABCB1—Betamethasone—hematologic cancer	0.00303	0.00573	CbGbCtD
Apixaban—ABCB1—Gemcitabine—hematologic cancer	0.003	0.00568	CbGbCtD
Apixaban—ABCB1—Prednisolone—hematologic cancer	0.00299	0.00565	CbGbCtD
Apixaban—CYP3A4—Cytarabine—hematologic cancer	0.00295	0.00559	CbGbCtD
Apixaban—CYP3A4—Teniposide—hematologic cancer	0.00291	0.00551	CbGbCtD
Apixaban—ABCB1—Prednisone—hematologic cancer	0.00282	0.00534	CbGbCtD
Apixaban—CYP3A5—Dexamethasone—hematologic cancer	0.00271	0.00512	CbGbCtD
Apixaban—CYP3A4—Ifosfamide—hematologic cancer	0.00269	0.00508	CbGbCtD
Apixaban—ABCB1—Irinotecan—hematologic cancer	0.00267	0.00506	CbGbCtD
Apixaban—CYP2C8—Dexamethasone—hematologic cancer	0.0026	0.00493	CbGbCtD
Apixaban—CYP3A4—Imatinib—hematologic cancer	0.00257	0.00486	CbGbCtD
Apixaban—CYP1A2—Etoposide—hematologic cancer	0.00245	0.00464	CbGbCtD
Apixaban—CYP3A4—Ruxolitinib—hematologic cancer	0.00242	0.00457	CbGbCtD
Apixaban—ABCB1—Vinblastine—hematologic cancer	0.00238	0.0045	CbGbCtD
Apixaban—ABCB1—Vincristine—hematologic cancer	0.00234	0.00442	CbGbCtD
Apixaban—CYP3A4—Nilotinib—hematologic cancer	0.00233	0.00441	CbGbCtD
Apixaban—CYP3A4—Vinorelbine—hematologic cancer	0.00231	0.00438	CbGbCtD
Apixaban—CYP2C9—Cisplatin—hematologic cancer	0.00225	0.00425	CbGbCtD
Apixaban—CYP2C19—Dexamethasone—hematologic cancer	0.00218	0.00413	CbGbCtD
Apixaban—ABCB1—Cisplatin—hematologic cancer	0.00218	0.00413	CbGbCtD
Apixaban—ABCB1—Etoposide—hematologic cancer	0.00214	0.00405	CbGbCtD
Apixaban—CYP3A4—Triamcinolone—hematologic cancer	0.00211	0.004	CbGbCtD
Apixaban—CYP3A4—Dasatinib—hematologic cancer	0.00206	0.0039	CbGbCtD
Apixaban—CYP3A4—Mitoxantrone—hematologic cancer	0.00204	0.00385	CbGbCtD
Apixaban—CYP2C9—Dexamethasone—hematologic cancer	0.00182	0.00344	CbGbCtD
Apixaban—CYP3A4—Betamethasone—hematologic cancer	0.00181	0.00343	CbGbCtD
Apixaban—CYP3A4—Prednisolone—hematologic cancer	0.00179	0.00339	CbGbCtD
Apixaban—ABCB1—Dexamethasone—hematologic cancer	0.00176	0.00333	CbGbCtD
Apixaban—F10—hematopoietic system—hematologic cancer	0.00174	0.109	CbGeAlD
Apixaban—CYP3A4—Prednisone—hematologic cancer	0.00169	0.0032	CbGbCtD
Apixaban—CYP3A4—Irinotecan—hematologic cancer	0.0016	0.00303	CbGbCtD
Apixaban—ABCB1—Doxorubicin—hematologic cancer	0.00146	0.00277	CbGbCtD
Apixaban—CYP3A4—Vinblastine—hematologic cancer	0.00142	0.0027	CbGbCtD
Apixaban—ABCB1—Methotrexate—hematologic cancer	0.00142	0.00268	CbGbCtD
Apixaban—CYP3A4—Vincristine—hematologic cancer	0.0014	0.00265	CbGbCtD
Apixaban—CYP3A4—Etoposide—hematologic cancer	0.00128	0.00243	CbGbCtD
Apixaban—F10—blood—hematologic cancer	0.00115	0.0723	CbGeAlD
Apixaban—CYP3A4—Dexamethasone—hematologic cancer	0.00106	0.002	CbGbCtD
Apixaban—F10—lung—hematologic cancer	0.00101	0.0634	CbGeAlD
Apixaban—F10—testis—hematologic cancer	0.000951	0.0598	CbGeAlD
Apixaban—CYP3A4—Doxorubicin—hematologic cancer	0.000876	0.00166	CbGbCtD
Apixaban—CYP2J2—lung—hematologic cancer	0.000826	0.052	CbGeAlD
Apixaban—CYP2J2—testis—hematologic cancer	0.00078	0.049	CbGeAlD
Apixaban—F10—lymph node—hematologic cancer	0.00069	0.0434	CbGeAlD
Apixaban—CYP2C19—hematopoietic system—hematologic cancer	0.000636	0.04	CbGeAlD
Apixaban—CYP2C8—hematopoietic system—hematologic cancer	0.000555	0.0349	CbGeAlD
Apixaban—CYP1A2—hematopoietic system—hematologic cancer	0.000519	0.0326	CbGeAlD
Apixaban—CYP3A5—hematopoietic system—hematologic cancer	0.000501	0.0315	CbGeAlD
Apixaban—CYP2C9—hematopoietic system—hematologic cancer	0.000493	0.031	CbGeAlD
Apixaban—CYP2C19—blood—hematologic cancer	0.000421	0.0265	CbGeAlD
Apixaban—CYP3A4—hematopoietic system—hematologic cancer	0.000376	0.0236	CbGeAlD
Apixaban—CYP2C8—blood—hematologic cancer	0.000368	0.0231	CbGeAlD
Apixaban—ABCG2—blood—hematologic cancer	0.000357	0.0225	CbGeAlD
Apixaban—ABCG2—bone marrow—hematologic cancer	0.000346	0.0217	CbGeAlD
Apixaban—CYP1A2—blood—hematologic cancer	0.000344	0.0216	CbGeAlD
Apixaban—CYP3A5—blood—hematologic cancer	0.000332	0.0209	CbGeAlD
Apixaban—CYP2C9—blood—hematologic cancer	0.000327	0.0205	CbGeAlD
Apixaban—ABCG2—lung—hematologic cancer	0.000313	0.0197	CbGeAlD
Apixaban—CYP2C8—testis—hematologic cancer	0.000304	0.0191	CbGeAlD
Apixaban—CYP1A2—lung—hematologic cancer	0.000302	0.019	CbGeAlD
Apixaban—ABCG2—testis—hematologic cancer	0.000296	0.0186	CbGeAlD
Apixaban—CYP3A5—lung—hematologic cancer	0.000291	0.0183	CbGeAlD
Apixaban—ABCB1—hematopoietic system—hematologic cancer	0.000266	0.0167	CbGeAlD
Apixaban—CYP3A4—blood—hematologic cancer	0.000249	0.0157	CbGeAlD
Apixaban—ABCG2—lymph node—hematologic cancer	0.000214	0.0135	CbGeAlD
Apixaban—ABCB1—gonad—hematologic cancer	0.000202	0.0127	CbGeAlD
Apixaban—ABCB1—blood—hematologic cancer	0.000176	0.0111	CbGeAlD
Apixaban—ABCB1—bone marrow—hematologic cancer	0.000171	0.0107	CbGeAlD
Apixaban—ABCB1—lung—hematologic cancer	0.000155	0.00971	CbGeAlD
Apixaban—ABCB1—testis—hematologic cancer	0.000146	0.00917	CbGeAlD
Apixaban—ABCB1—lymph node—hematologic cancer	0.000106	0.00664	CbGeAlD
Apixaban—Hypersensitivity—Bortezomib—hematologic cancer	4.82e-05	0.000312	CcSEcCtD
Apixaban—Hypotension—Gemcitabine—hematologic cancer	4.79e-05	0.00031	CcSEcCtD
Apixaban—Gastrointestinal disorder—Ifosfamide—hematologic cancer	4.79e-05	0.00031	CcSEcCtD
Apixaban—Anaphylactic shock—Cisplatin—hematologic cancer	4.78e-05	0.00031	CcSEcCtD
Apixaban—Hypersensitivity—Bleomycin—hematologic cancer	4.78e-05	0.00031	CcSEcCtD
Apixaban—Nausea—Cladribine—hematologic cancer	4.76e-05	0.000308	CcSEcCtD
Apixaban—Syncope—Prednisolone—hematologic cancer	4.75e-05	0.000307	CcSEcCtD
Apixaban—Eye disorder—Dexamethasone—hematologic cancer	4.74e-05	0.000307	CcSEcCtD
Apixaban—Eye disorder—Betamethasone—hematologic cancer	4.74e-05	0.000307	CcSEcCtD
Apixaban—Loss of consciousness—Etoposide—hematologic cancer	4.72e-05	0.000305	CcSEcCtD
Apixaban—Hypersensitivity—Vinorelbine—hematologic cancer	4.7e-05	0.000305	CcSEcCtD
Apixaban—Dizziness—Lenalidomide—hematologic cancer	4.7e-05	0.000304	CcSEcCtD
Apixaban—Nervous system disorder—Cisplatin—hematologic cancer	4.69e-05	0.000304	CcSEcCtD
Apixaban—Thrombocytopenia—Cisplatin—hematologic cancer	4.68e-05	0.000303	CcSEcCtD
Apixaban—Gastrointestinal disorder—Vincristine—hematologic cancer	4.67e-05	0.000302	CcSEcCtD
Apixaban—Loss of consciousness—Prednisolone—hematologic cancer	4.65e-05	0.000301	CcSEcCtD
Apixaban—Skin disorder—Cisplatin—hematologic cancer	4.64e-05	0.000301	CcSEcCtD
Apixaban—Dizziness—Hydroxyurea—hematologic cancer	4.63e-05	0.0003	CcSEcCtD
Apixaban—Gastrointestinal haemorrhage—Doxorubicin—hematologic cancer	4.62e-05	0.000299	CcSEcCtD
Apixaban—Liver function test abnormal—Epirubicin—hematologic cancer	4.61e-05	0.000299	CcSEcCtD
Apixaban—Rash—Melphalan—hematologic cancer	4.61e-05	0.000298	CcSEcCtD
Apixaban—Dermatitis—Melphalan—hematologic cancer	4.6e-05	0.000298	CcSEcCtD
Apixaban—Angiopathy—Dexamethasone—hematologic cancer	4.6e-05	0.000298	CcSEcCtD
Apixaban—Angiopathy—Betamethasone—hematologic cancer	4.6e-05	0.000298	CcSEcCtD
Apixaban—Nausea—Vinblastine—hematologic cancer	4.56e-05	0.000295	CcSEcCtD
Apixaban—Gastrointestinal disorder—Irinotecan—hematologic cancer	4.54e-05	0.000294	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Etoposide—hematologic cancer	4.54e-05	0.000294	CcSEcCtD
Apixaban—Breast disorder—Epirubicin—hematologic cancer	4.51e-05	0.000292	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Epirubicin—hematologic cancer	4.5e-05	0.000291	CcSEcCtD
Apixaban—Hypersensitivity—Thiotepa—hematologic cancer	4.49e-05	0.000291	CcSEcCtD
Apixaban—Rash—Lenalidomide—hematologic cancer	4.48e-05	0.00029	CcSEcCtD
Apixaban—Dermatitis—Lenalidomide—hematologic cancer	4.47e-05	0.00029	CcSEcCtD
Apixaban—Hypotension—Cisplatin—hematologic cancer	4.47e-05	0.000289	CcSEcCtD
Apixaban—Haemoglobin—Prednisone—hematologic cancer	4.44e-05	0.000288	CcSEcCtD
Apixaban—Gastrointestinal disorder—Gemcitabine—hematologic cancer	4.43e-05	0.000287	CcSEcCtD
Apixaban—Haemorrhage—Prednisone—hematologic cancer	4.42e-05	0.000286	CcSEcCtD
Apixaban—Rash—Hydroxyurea—hematologic cancer	4.42e-05	0.000286	CcSEcCtD
Apixaban—Dermatitis—Hydroxyurea—hematologic cancer	4.41e-05	0.000286	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Epirubicin—hematologic cancer	4.4e-05	0.000285	CcSEcCtD
Apixaban—Anaphylactic shock—Etoposide—hematologic cancer	4.38e-05	0.000284	CcSEcCtD
Apixaban—Syncope—Triamcinolone—hematologic cancer	4.36e-05	0.000283	CcSEcCtD
Apixaban—Hypersensitivity—Thalidomide—hematologic cancer	4.34e-05	0.000281	CcSEcCtD
Apixaban—Connective tissue disorder—Prednisone—hematologic cancer	4.34e-05	0.000281	CcSEcCtD
Apixaban—Nausea—Melphalan—hematologic cancer	4.34e-05	0.000281	CcSEcCtD
Apixaban—Dizziness—Bortezomib—hematologic cancer	4.32e-05	0.00028	CcSEcCtD
Apixaban—Anaphylactic shock—Prednisolone—hematologic cancer	4.32e-05	0.00028	CcSEcCtD
Apixaban—Thrombocytopenia—Etoposide—hematologic cancer	4.29e-05	0.000278	CcSEcCtD
Apixaban—Loss of consciousness—Triamcinolone—hematologic cancer	4.28e-05	0.000277	CcSEcCtD
Apixaban—Liver function test abnormal—Doxorubicin—hematologic cancer	4.27e-05	0.000276	CcSEcCtD
Apixaban—Skin disorder—Etoposide—hematologic cancer	4.25e-05	0.000275	CcSEcCtD
Apixaban—Shock—Prednisolone—hematologic cancer	4.25e-05	0.000275	CcSEcCtD
Apixaban—Dizziness—Vinorelbine—hematologic cancer	4.22e-05	0.000273	CcSEcCtD
Apixaban—Nausea—Lenalidomide—hematologic cancer	4.22e-05	0.000273	CcSEcCtD
Apixaban—Breast disorder—Doxorubicin—hematologic cancer	4.18e-05	0.00027	CcSEcCtD
Apixaban—Hypersensitivity—Carmustine—hematologic cancer	4.17e-05	0.00027	CcSEcCtD
Apixaban—Aspartate aminotransferase increased—Doxorubicin—hematologic cancer	4.16e-05	0.000269	CcSEcCtD
Apixaban—Nausea—Hydroxyurea—hematologic cancer	4.16e-05	0.000269	CcSEcCtD
Apixaban—Hypersensitivity—Alitretinoin—hematologic cancer	4.13e-05	0.000268	CcSEcCtD
Apixaban—Eye disorder—Prednisone—hematologic cancer	4.13e-05	0.000267	CcSEcCtD
Apixaban—Gastrointestinal disorder—Cisplatin—hematologic cancer	4.13e-05	0.000267	CcSEcCtD
Apixaban—Rash—Bortezomib—hematologic cancer	4.12e-05	0.000267	CcSEcCtD
Apixaban—Dermatitis—Bortezomib—hematologic cancer	4.12e-05	0.000267	CcSEcCtD
Apixaban—Hypotension—Etoposide—hematologic cancer	4.09e-05	0.000265	CcSEcCtD
Apixaban—Rash—Bleomycin—hematologic cancer	4.09e-05	0.000265	CcSEcCtD
Apixaban—Dermatitis—Bleomycin—hematologic cancer	4.09e-05	0.000265	CcSEcCtD
Apixaban—Hypersensitivity—Ifosfamide—hematologic cancer	4.08e-05	0.000265	CcSEcCtD
Apixaban—Alanine aminotransferase increased—Doxorubicin—hematologic cancer	4.07e-05	0.000264	CcSEcCtD
Apixaban—Dizziness—Thiotepa—hematologic cancer	4.03e-05	0.000261	CcSEcCtD
Apixaban—Rash—Vinorelbine—hematologic cancer	4.02e-05	0.000261	CcSEcCtD
Apixaban—Dermatitis—Vinorelbine—hematologic cancer	4.02e-05	0.00026	CcSEcCtD
Apixaban—Angiopathy—Prednisone—hematologic cancer	4.01e-05	0.00026	CcSEcCtD
Apixaban—Immune system disorder—Prednisone—hematologic cancer	3.99e-05	0.000258	CcSEcCtD
Apixaban—Hypersensitivity—Vincristine—hematologic cancer	3.98e-05	0.000258	CcSEcCtD
Apixaban—Anaphylactic shock—Triamcinolone—hematologic cancer	3.97e-05	0.000257	CcSEcCtD
Apixaban—Syncope—Betamethasone—hematologic cancer	3.96e-05	0.000256	CcSEcCtD
Apixaban—Syncope—Dexamethasone—hematologic cancer	3.96e-05	0.000256	CcSEcCtD
Apixaban—Haematuria—Methotrexate—hematologic cancer	3.92e-05	0.000254	CcSEcCtD
Apixaban—Shock—Triamcinolone—hematologic cancer	3.91e-05	0.000253	CcSEcCtD
Apixaban—Dizziness—Thalidomide—hematologic cancer	3.9e-05	0.000252	CcSEcCtD
Apixaban—Hepatobiliary disease—Methotrexate—hematologic cancer	3.89e-05	0.000252	CcSEcCtD
Apixaban—Nausea—Bortezomib—hematologic cancer	3.88e-05	0.000251	CcSEcCtD
Apixaban—Loss of consciousness—Dexamethasone—hematologic cancer	3.88e-05	0.000251	CcSEcCtD
Apixaban—Loss of consciousness—Betamethasone—hematologic cancer	3.88e-05	0.000251	CcSEcCtD
Apixaban—Epistaxis—Methotrexate—hematologic cancer	3.88e-05	0.000251	CcSEcCtD
Apixaban—Hypersensitivity—Mitoxantrone—hematologic cancer	3.88e-05	0.000251	CcSEcCtD
Apixaban—Hypersensitivity—Irinotecan—hematologic cancer	3.88e-05	0.000251	CcSEcCtD
Apixaban—Nausea—Bleomycin—hematologic cancer	3.85e-05	0.00025	CcSEcCtD
Apixaban—Rash—Thiotepa—hematologic cancer	3.84e-05	0.000249	CcSEcCtD
Apixaban—Dermatitis—Thiotepa—hematologic cancer	3.84e-05	0.000249	CcSEcCtD
Apixaban—Nausea—Vinorelbine—hematologic cancer	3.79e-05	0.000246	CcSEcCtD
Apixaban—Gastrointestinal disorder—Etoposide—hematologic cancer	3.78e-05	0.000245	CcSEcCtD
Apixaban—Dizziness—Carmustine—hematologic cancer	3.74e-05	0.000242	CcSEcCtD
Apixaban—Rash—Thalidomide—hematologic cancer	3.72e-05	0.000241	CcSEcCtD
Apixaban—Dermatitis—Thalidomide—hematologic cancer	3.71e-05	0.000241	CcSEcCtD
Apixaban—Haemoglobin—Methotrexate—hematologic cancer	3.71e-05	0.00024	CcSEcCtD
Apixaban—Dizziness—Alitretinoin—hematologic cancer	3.71e-05	0.00024	CcSEcCtD
Apixaban—Haemorrhage—Methotrexate—hematologic cancer	3.69e-05	0.000239	CcSEcCtD
Apixaban—Haematuria—Epirubicin—hematologic cancer	3.67e-05	0.000238	CcSEcCtD
Apixaban—Dizziness—Ifosfamide—hematologic cancer	3.67e-05	0.000237	CcSEcCtD
Apixaban—Urinary tract disorder—Methotrexate—hematologic cancer	3.65e-05	0.000236	CcSEcCtD
Apixaban—Hepatobiliary disease—Epirubicin—hematologic cancer	3.64e-05	0.000236	CcSEcCtD
Apixaban—Epistaxis—Epirubicin—hematologic cancer	3.63e-05	0.000235	CcSEcCtD
Apixaban—Nausea—Thiotepa—hematologic cancer	3.62e-05	0.000234	CcSEcCtD
Apixaban—Urethral disorder—Methotrexate—hematologic cancer	3.62e-05	0.000234	CcSEcCtD
Apixaban—Anaphylactic shock—Dexamethasone—hematologic cancer	3.6e-05	0.000233	CcSEcCtD
Apixaban—Anaphylactic shock—Betamethasone—hematologic cancer	3.6e-05	0.000233	CcSEcCtD
Apixaban—Dizziness—Vincristine—hematologic cancer	3.57e-05	0.000231	CcSEcCtD
Apixaban—Rash—Carmustine—hematologic cancer	3.57e-05	0.000231	CcSEcCtD
Apixaban—Dermatitis—Carmustine—hematologic cancer	3.57e-05	0.000231	CcSEcCtD
Apixaban—Anaemia—Prednisone—hematologic cancer	3.55e-05	0.00023	CcSEcCtD
Apixaban—Shock—Dexamethasone—hematologic cancer	3.55e-05	0.00023	CcSEcCtD
Apixaban—Shock—Betamethasone—hematologic cancer	3.55e-05	0.00023	CcSEcCtD
Apixaban—Rash—Alitretinoin—hematologic cancer	3.54e-05	0.000229	CcSEcCtD
Apixaban—Nervous system disorder—Dexamethasone—hematologic cancer	3.53e-05	0.000229	CcSEcCtD
Apixaban—Nervous system disorder—Betamethasone—hematologic cancer	3.53e-05	0.000229	CcSEcCtD
Apixaban—Dermatitis—Alitretinoin—hematologic cancer	3.53e-05	0.000229	CcSEcCtD
Apixaban—Thrombocytopenia—Betamethasone—hematologic cancer	3.53e-05	0.000229	CcSEcCtD
Apixaban—Thrombocytopenia—Dexamethasone—hematologic cancer	3.53e-05	0.000229	CcSEcCtD
Apixaban—Hypersensitivity—Cisplatin—hematologic cancer	3.52e-05	0.000228	CcSEcCtD
Apixaban—Nausea—Thalidomide—hematologic cancer	3.5e-05	0.000227	CcSEcCtD
Apixaban—Rash—Ifosfamide—hematologic cancer	3.5e-05	0.000226	CcSEcCtD
Apixaban—Dermatitis—Ifosfamide—hematologic cancer	3.49e-05	0.000226	CcSEcCtD
Apixaban—Dizziness—Irinotecan—hematologic cancer	3.48e-05	0.000225	CcSEcCtD
Apixaban—Haemoglobin—Epirubicin—hematologic cancer	3.47e-05	0.000225	CcSEcCtD
Apixaban—Haemorrhage—Epirubicin—hematologic cancer	3.45e-05	0.000224	CcSEcCtD
Apixaban—Eye disorder—Methotrexate—hematologic cancer	3.45e-05	0.000223	CcSEcCtD
Apixaban—Syncope—Prednisone—hematologic cancer	3.45e-05	0.000223	CcSEcCtD
Apixaban—Urinary tract disorder—Epirubicin—hematologic cancer	3.41e-05	0.000221	CcSEcCtD
Apixaban—Rash—Vincristine—hematologic cancer	3.41e-05	0.000221	CcSEcCtD
Apixaban—Dermatitis—Vincristine—hematologic cancer	3.4e-05	0.000221	CcSEcCtD
Apixaban—Haematuria—Doxorubicin—hematologic cancer	3.39e-05	0.00022	CcSEcCtD
Apixaban—Connective tissue disorder—Epirubicin—hematologic cancer	3.39e-05	0.00022	CcSEcCtD
Apixaban—Urethral disorder—Epirubicin—hematologic cancer	3.39e-05	0.000219	CcSEcCtD
Apixaban—Loss of consciousness—Prednisone—hematologic cancer	3.38e-05	0.000219	CcSEcCtD
Apixaban—Hepatobiliary disease—Doxorubicin—hematologic cancer	3.37e-05	0.000218	CcSEcCtD
Apixaban—Hypotension—Betamethasone—hematologic cancer	3.37e-05	0.000218	CcSEcCtD
Apixaban—Hypotension—Dexamethasone—hematologic cancer	3.37e-05	0.000218	CcSEcCtD
Apixaban—Nausea—Carmustine—hematologic cancer	3.36e-05	0.000218	CcSEcCtD
Apixaban—Epistaxis—Doxorubicin—hematologic cancer	3.36e-05	0.000218	CcSEcCtD
Apixaban—Angiopathy—Methotrexate—hematologic cancer	3.35e-05	0.000217	CcSEcCtD
Apixaban—Immune system disorder—Methotrexate—hematologic cancer	3.33e-05	0.000216	CcSEcCtD
Apixaban—Nausea—Alitretinoin—hematologic cancer	3.33e-05	0.000216	CcSEcCtD
Apixaban—Mediastinal disorder—Methotrexate—hematologic cancer	3.33e-05	0.000215	CcSEcCtD
Apixaban—Rash—Mitoxantrone—hematologic cancer	3.32e-05	0.000215	CcSEcCtD
Apixaban—Rash—Irinotecan—hematologic cancer	3.32e-05	0.000215	CcSEcCtD
Apixaban—Dermatitis—Mitoxantrone—hematologic cancer	3.32e-05	0.000215	CcSEcCtD
Apixaban—Dermatitis—Irinotecan—hematologic cancer	3.32e-05	0.000215	CcSEcCtD
Apixaban—Nausea—Ifosfamide—hematologic cancer	3.29e-05	0.000213	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	3.25e-05	0.000211	CcSEcCtD
Apixaban—Rash—Gemcitabine—hematologic cancer	3.23e-05	0.000209	CcSEcCtD
Apixaban—Dermatitis—Gemcitabine—hematologic cancer	3.23e-05	0.000209	CcSEcCtD
Apixaban—Eye disorder—Epirubicin—hematologic cancer	3.23e-05	0.000209	CcSEcCtD
Apixaban—Hypersensitivity—Etoposide—hematologic cancer	3.23e-05	0.000209	CcSEcCtD
Apixaban—Haemoglobin—Doxorubicin—hematologic cancer	3.21e-05	0.000208	CcSEcCtD
Apixaban—Nausea—Vincristine—hematologic cancer	3.21e-05	0.000208	CcSEcCtD
Apixaban—Haemorrhage—Doxorubicin—hematologic cancer	3.2e-05	0.000207	CcSEcCtD
Apixaban—Hypersensitivity—Prednisolone—hematologic cancer	3.18e-05	0.000206	CcSEcCtD
Apixaban—Urinary tract disorder—Doxorubicin—hematologic cancer	3.16e-05	0.000204	CcSEcCtD
Apixaban—Connective tissue disorder—Doxorubicin—hematologic cancer	3.14e-05	0.000203	CcSEcCtD
Apixaban—Anaphylactic shock—Prednisone—hematologic cancer	3.14e-05	0.000203	CcSEcCtD
Apixaban—Angiopathy—Epirubicin—hematologic cancer	3.13e-05	0.000203	CcSEcCtD
Apixaban—Urethral disorder—Doxorubicin—hematologic cancer	3.13e-05	0.000203	CcSEcCtD
Apixaban—Nausea—Irinotecan—hematologic cancer	3.13e-05	0.000203	CcSEcCtD
Apixaban—Nausea—Mitoxantrone—hematologic cancer	3.13e-05	0.000203	CcSEcCtD
Apixaban—Immune system disorder—Epirubicin—hematologic cancer	3.12e-05	0.000202	CcSEcCtD
Apixaban—Mediastinal disorder—Epirubicin—hematologic cancer	3.11e-05	0.000202	CcSEcCtD
Apixaban—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.11e-05	0.000201	CcSEcCtD
Apixaban—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.11e-05	0.000201	CcSEcCtD
Apixaban—Shock—Prednisone—hematologic cancer	3.09e-05	0.0002	CcSEcCtD
Apixaban—Nervous system disorder—Prednisone—hematologic cancer	3.08e-05	0.000199	CcSEcCtD
Apixaban—Skin disorder—Prednisone—hematologic cancer	3.05e-05	0.000197	CcSEcCtD
Apixaban—Nausea—Gemcitabine—hematologic cancer	3.05e-05	0.000197	CcSEcCtD
Apixaban—Rash—Cisplatin—hematologic cancer	3.01e-05	0.000195	CcSEcCtD
Apixaban—Dermatitis—Cisplatin—hematologic cancer	3.01e-05	0.000195	CcSEcCtD
Apixaban—Eye disorder—Doxorubicin—hematologic cancer	2.99e-05	0.000193	CcSEcCtD
Apixaban—Anaemia—Methotrexate—hematologic cancer	2.97e-05	0.000192	CcSEcCtD
Apixaban—Hypersensitivity—Triamcinolone—hematologic cancer	2.93e-05	0.00019	CcSEcCtD
Apixaban—Angiopathy—Doxorubicin—hematologic cancer	2.9e-05	0.000188	CcSEcCtD
Apixaban—Dizziness—Etoposide—hematologic cancer	2.9e-05	0.000188	CcSEcCtD
Apixaban—Immune system disorder—Doxorubicin—hematologic cancer	2.89e-05	0.000187	CcSEcCtD
Apixaban—Mediastinal disorder—Doxorubicin—hematologic cancer	2.88e-05	0.000187	CcSEcCtD
Apixaban—Dizziness—Prednisolone—hematologic cancer	2.86e-05	0.000185	CcSEcCtD
Apixaban—Nausea—Cisplatin—hematologic cancer	2.84e-05	0.000184	CcSEcCtD
Apixaban—Anaemia—Epirubicin—hematologic cancer	2.78e-05	0.00018	CcSEcCtD
Apixaban—Rash—Etoposide—hematologic cancer	2.76e-05	0.000179	CcSEcCtD
Apixaban—Dermatitis—Etoposide—hematologic cancer	2.76e-05	0.000179	CcSEcCtD
Apixaban—Rash—Prednisolone—hematologic cancer	2.72e-05	0.000176	CcSEcCtD
Apixaban—Dermatitis—Prednisolone—hematologic cancer	2.72e-05	0.000176	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.72e-05	0.000176	CcSEcCtD
Apixaban—Syncope—Epirubicin—hematologic cancer	2.7e-05	0.000175	CcSEcCtD
Apixaban—Loss of consciousness—Epirubicin—hematologic cancer	2.64e-05	0.000171	CcSEcCtD
Apixaban—Dizziness—Triamcinolone—hematologic cancer	2.63e-05	0.00017	CcSEcCtD
Apixaban—Anaphylactic shock—Methotrexate—hematologic cancer	2.62e-05	0.00017	CcSEcCtD
Apixaban—Nausea—Etoposide—hematologic cancer	2.6e-05	0.000168	CcSEcCtD
Apixaban—Nervous system disorder—Methotrexate—hematologic cancer	2.57e-05	0.000167	CcSEcCtD
Apixaban—Anaemia—Doxorubicin—hematologic cancer	2.57e-05	0.000167	CcSEcCtD
Apixaban—Thrombocytopenia—Methotrexate—hematologic cancer	2.57e-05	0.000166	CcSEcCtD
Apixaban—Nausea—Prednisolone—hematologic cancer	2.57e-05	0.000166	CcSEcCtD
Apixaban—Skin disorder—Methotrexate—hematologic cancer	2.55e-05	0.000165	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.54e-05	0.000165	CcSEcCtD
Apixaban—Rash—Triamcinolone—hematologic cancer	2.5e-05	0.000162	CcSEcCtD
Apixaban—Dermatitis—Triamcinolone—hematologic cancer	2.5e-05	0.000162	CcSEcCtD
Apixaban—Syncope—Doxorubicin—hematologic cancer	2.5e-05	0.000162	CcSEcCtD
Apixaban—Anaphylactic shock—Epirubicin—hematologic cancer	2.45e-05	0.000159	CcSEcCtD
Apixaban—Hypotension—Methotrexate—hematologic cancer	2.45e-05	0.000159	CcSEcCtD
Apixaban—Loss of consciousness—Doxorubicin—hematologic cancer	2.45e-05	0.000158	CcSEcCtD
Apixaban—Shock—Epirubicin—hematologic cancer	2.41e-05	0.000156	CcSEcCtD
Apixaban—Nervous system disorder—Epirubicin—hematologic cancer	2.41e-05	0.000156	CcSEcCtD
Apixaban—Thrombocytopenia—Epirubicin—hematologic cancer	2.4e-05	0.000156	CcSEcCtD
Apixaban—Skin disorder—Epirubicin—hematologic cancer	2.38e-05	0.000154	CcSEcCtD
Apixaban—Dizziness—Betamethasone—hematologic cancer	2.38e-05	0.000154	CcSEcCtD
Apixaban—Dizziness—Dexamethasone—hematologic cancer	2.38e-05	0.000154	CcSEcCtD
Apixaban—Nausea—Triamcinolone—hematologic cancer	2.36e-05	0.000153	CcSEcCtD
Apixaban—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.35e-05	0.000152	CcSEcCtD
Apixaban—Hypersensitivity—Prednisone—hematologic cancer	2.31e-05	0.00015	CcSEcCtD
Apixaban—Hypotension—Epirubicin—hematologic cancer	2.29e-05	0.000149	CcSEcCtD
Apixaban—Rash—Betamethasone—hematologic cancer	2.27e-05	0.000147	CcSEcCtD
Apixaban—Rash—Dexamethasone—hematologic cancer	2.27e-05	0.000147	CcSEcCtD
Apixaban—Anaphylactic shock—Doxorubicin—hematologic cancer	2.27e-05	0.000147	CcSEcCtD
Apixaban—Dermatitis—Dexamethasone—hematologic cancer	2.27e-05	0.000147	CcSEcCtD
Apixaban—Dermatitis—Betamethasone—hematologic cancer	2.27e-05	0.000147	CcSEcCtD
Apixaban—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.26e-05	0.000147	CcSEcCtD
Apixaban—Shock—Doxorubicin—hematologic cancer	2.23e-05	0.000145	CcSEcCtD
Apixaban—Nervous system disorder—Doxorubicin—hematologic cancer	2.23e-05	0.000144	CcSEcCtD
Apixaban—Thrombocytopenia—Doxorubicin—hematologic cancer	2.22e-05	0.000144	CcSEcCtD
Apixaban—Skin disorder—Doxorubicin—hematologic cancer	2.21e-05	0.000143	CcSEcCtD
Apixaban—Nausea—Dexamethasone—hematologic cancer	2.14e-05	0.000139	CcSEcCtD
Apixaban—Nausea—Betamethasone—hematologic cancer	2.14e-05	0.000139	CcSEcCtD
Apixaban—Hypotension—Doxorubicin—hematologic cancer	2.12e-05	0.000137	CcSEcCtD
Apixaban—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.12e-05	0.000137	CcSEcCtD
Apixaban—Dizziness—Prednisone—hematologic cancer	2.08e-05	0.000134	CcSEcCtD
Apixaban—Rash—Prednisone—hematologic cancer	1.98e-05	0.000128	CcSEcCtD
Apixaban—Dermatitis—Prednisone—hematologic cancer	1.98e-05	0.000128	CcSEcCtD
Apixaban—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.96e-05	0.000127	CcSEcCtD
Apixaban—Hypersensitivity—Methotrexate—hematologic cancer	1.93e-05	0.000125	CcSEcCtD
Apixaban—Nausea—Prednisone—hematologic cancer	1.86e-05	0.000121	CcSEcCtD
Apixaban—Hypersensitivity—Epirubicin—hematologic cancer	1.81e-05	0.000117	CcSEcCtD
Apixaban—Dizziness—Methotrexate—hematologic cancer	1.73e-05	0.000112	CcSEcCtD
Apixaban—Hypersensitivity—Doxorubicin—hematologic cancer	1.67e-05	0.000108	CcSEcCtD
Apixaban—Rash—Methotrexate—hematologic cancer	1.65e-05	0.000107	CcSEcCtD
Apixaban—Dermatitis—Methotrexate—hematologic cancer	1.65e-05	0.000107	CcSEcCtD
Apixaban—Dizziness—Epirubicin—hematologic cancer	1.62e-05	0.000105	CcSEcCtD
Apixaban—Nausea—Methotrexate—hematologic cancer	1.56e-05	0.000101	CcSEcCtD
Apixaban—Rash—Epirubicin—hematologic cancer	1.55e-05	0.0001	CcSEcCtD
Apixaban—Dermatitis—Epirubicin—hematologic cancer	1.55e-05	0.0001	CcSEcCtD
Apixaban—Dizziness—Doxorubicin—hematologic cancer	1.5e-05	9.73e-05	CcSEcCtD
Apixaban—Nausea—Epirubicin—hematologic cancer	1.46e-05	9.44e-05	CcSEcCtD
Apixaban—Rash—Doxorubicin—hematologic cancer	1.43e-05	9.27e-05	CcSEcCtD
Apixaban—Dermatitis—Doxorubicin—hematologic cancer	1.43e-05	9.27e-05	CcSEcCtD
Apixaban—Nausea—Doxorubicin—hematologic cancer	1.35e-05	8.74e-05	CcSEcCtD
Apixaban—CYP3A5—Metabolism—CD44—hematologic cancer	4.65e-06	8.42e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—NUP214—hematologic cancer	4.64e-06	8.41e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NCOR2—hematologic cancer	4.62e-06	8.36e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.6e-06	8.32e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—NCOA3—hematologic cancer	4.57e-06	8.26e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ADCY7—hematologic cancer	4.57e-06	8.26e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—MTR—hematologic cancer	4.55e-06	8.23e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ABCG2—hematologic cancer	4.55e-06	8.23e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ALOX5—hematologic cancer	4.54e-06	8.21e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—NUP214—hematologic cancer	4.53e-06	8.2e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.53e-06	8.19e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.47e-06	8.09e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ENO2—hematologic cancer	4.46e-06	8.08e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ABCG2—hematologic cancer	4.44e-06	8.04e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—MTR—hematologic cancer	4.44e-06	8.04e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CYCS—hematologic cancer	4.4e-06	7.97e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—IDH1—hematologic cancer	4.4e-06	7.96e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—MTHFR—hematologic cancer	4.4e-06	7.96e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—NUP98—hematologic cancer	4.39e-06	7.95e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	4.37e-06	7.92e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ENO2—hematologic cancer	4.36e-06	7.88e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—TXN—hematologic cancer	4.35e-06	7.87e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ABCC3—hematologic cancer	4.35e-06	7.87e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTO1—hematologic cancer	4.35e-06	7.87e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GSTT1—hematologic cancer	4.33e-06	7.83e-05	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—PIK3CA—hematologic cancer	4.29e-06	7.77e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.28e-06	7.74e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ADCY7—hematologic cancer	4.27e-06	7.72e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—NCOA3—hematologic cancer	4.27e-06	7.72e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.26e-06	7.71e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—SPHK1—hematologic cancer	4.26e-06	7.7e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—FHL2—hematologic cancer	4.25e-06	7.68e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—NUP214—hematologic cancer	4.24e-06	7.66e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—SDC1—hematologic cancer	4.23e-06	7.66e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GSTT1—hematologic cancer	4.22e-06	7.64e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.19e-06	7.58e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—AGRN—hematologic cancer	4.16e-06	7.54e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—MTR—hematologic cancer	4.15e-06	7.51e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ABCG2—hematologic cancer	4.15e-06	7.51e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—SDC1—hematologic cancer	4.13e-06	7.47e-05	CbGpPWpGaD
Apixaban—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	4.1e-06	7.42e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—UGT1A1—hematologic cancer	4.09e-06	7.4e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ENO2—hematologic cancer	4.07e-06	7.36e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.04e-06	7.31e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CD44—hematologic cancer	4.03e-06	7.29e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—NQO1—hematologic cancer	4.03e-06	7.29e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.99e-06	7.22e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—SLC22A1—hematologic cancer	3.98e-06	7.2e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CRABP1—hematologic cancer	3.98e-06	7.2e-05	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.96e-06	7.16e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—IDH2—hematologic cancer	3.95e-06	7.14e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—HMMR—hematologic cancer	3.95e-06	7.14e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSTT1—hematologic cancer	3.95e-06	7.14e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.95e-06	7.14e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.89e-06	7.03e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GSTP1—hematologic cancer	3.88e-06	7.02e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALOX5—hematologic cancer	3.88e-06	7.02e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—SDC1—hematologic cancer	3.86e-06	6.98e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.82e-06	6.9e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CYCS—hematologic cancer	3.81e-06	6.9e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	3.79e-06	6.86e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NUP98—hematologic cancer	3.75e-06	6.79e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.71e-06	6.72e-05	CbGpPWpGaD
Apixaban—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.7e-06	6.7e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PIK3CG—hematologic cancer	3.7e-06	6.69e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.68e-06	6.67e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ABCB1—hematologic cancer	3.67e-06	6.65e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ADCY7—hematologic cancer	3.64e-06	6.6e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NCOA3—hematologic cancer	3.64e-06	6.6e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.64e-06	6.58e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NUP214—hematologic cancer	3.62e-06	6.55e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CA9—hematologic cancer	3.61e-06	6.53e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ACP5—hematologic cancer	3.61e-06	6.53e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CD44—hematologic cancer	3.6e-06	6.51e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—NQO1—hematologic cancer	3.6e-06	6.51e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.58e-06	6.48e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—NCOR1—hematologic cancer	3.57e-06	6.45e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—GSTM1—hematologic cancer	3.57e-06	6.45e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.56e-06	6.45e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—MTR—hematologic cancer	3.55e-06	6.42e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ABCG2—hematologic cancer	3.55e-06	6.42e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.52e-06	6.37e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—NQO1—hematologic cancer	3.51e-06	6.35e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CD44—hematologic cancer	3.51e-06	6.35e-05	CbGpPWpGaD
Apixaban—CYP2J2—Metabolism—AKT1—hematologic cancer	3.51e-06	6.34e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.48e-06	6.3e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ENO2—hematologic cancer	3.48e-06	6.29e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—CREBBP—hematologic cancer	3.43e-06	6.2e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.41e-06	6.17e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CYCS—hematologic cancer	3.4e-06	6.16e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—IDH1—hematologic cancer	3.39e-06	6.14e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	3.38e-06	6.12e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTT1—hematologic cancer	3.37e-06	6.1e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GSTP1—hematologic cancer	3.36e-06	6.08e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.36e-06	6.07e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.36e-06	6.07e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—TXN—hematologic cancer	3.36e-06	6.07e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CYCS—hematologic cancer	3.32e-06	6.01e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.32e-06	6.01e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—HSP90AA1—hematologic cancer	3.3e-06	5.97e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—SDC1—hematologic cancer	3.3e-06	5.96e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.29e-06	5.94e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—NQO1—hematologic cancer	3.28e-06	5.94e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CD44—hematologic cancer	3.28e-06	5.94e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.25e-06	5.88e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PIK3CD—hematologic cancer	3.25e-06	5.88e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.21e-06	5.81e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—ALB—hematologic cancer	3.21e-06	5.8e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ABCB1—hematologic cancer	3.18e-06	5.76e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.16e-06	5.71e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—MTHFR—hematologic cancer	3.15e-06	5.7e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.15e-06	5.7e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.11e-06	5.62e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CYCS—hematologic cancer	3.1e-06	5.62e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—GSTM1—hematologic cancer	3.09e-06	5.59e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—NCOR1—hematologic cancer	3.09e-06	5.59e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	3.08e-06	5.58e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.07e-06	5.56e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.07e-06	5.56e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PIK3R1—hematologic cancer	3.07e-06	5.55e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.04e-06	5.51e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GSTP1—hematologic cancer	3e-06	5.43e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.99e-06	5.41e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.97e-06	5.38e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GSTP1—hematologic cancer	2.93e-06	5.3e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.9e-06	5.25e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NUP98—hematologic cancer	2.9e-06	5.24e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ABCB1—hematologic cancer	2.84e-06	5.14e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PIK3CB—hematologic cancer	2.83e-06	5.12e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.81e-06	5.09e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.81e-06	5.09e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CD44—hematologic cancer	2.8e-06	5.07e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NQO1—hematologic cancer	2.8e-06	5.07e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NUP214—hematologic cancer	2.79e-06	5.05e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.78e-06	5.02e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—NCOR1—hematologic cancer	2.76e-06	4.99e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—GSTM1—hematologic cancer	2.76e-06	4.99e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.74e-06	4.97e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—MTR—hematologic cancer	2.74e-06	4.95e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.74e-06	4.95e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.74e-06	4.95e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—MTHFR—hematologic cancer	2.73e-06	4.94e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—NCOR1—hematologic cancer	2.69e-06	4.87e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—GSTM1—hematologic cancer	2.69e-06	4.87e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ENO2—hematologic cancer	2.68e-06	4.86e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CYCS—hematologic cancer	2.65e-06	4.8e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PIK3CG—hematologic cancer	2.65e-06	4.79e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.65e-06	4.79e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	2.64e-06	4.77e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.6e-06	4.71e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.59e-06	4.69e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—SDC1—hematologic cancer	2.54e-06	4.6e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.51e-06	4.55e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.51e-06	4.55e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—CREBBP—hematologic cancer	2.46e-06	4.44e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PTEN—hematologic cancer	2.45e-06	4.43e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.44e-06	4.41e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.41e-06	4.35e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—MTHFR—hematologic cancer	2.38e-06	4.3e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.37e-06	4.29e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.34e-06	4.23e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—EP300—hematologic cancer	2.33e-06	4.22e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PIK3CD—hematologic cancer	2.33e-06	4.21e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—ALB—hematologic cancer	2.3e-06	4.16e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PIK3CG—hematologic cancer	2.29e-06	4.15e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.26e-06	4.09e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.22e-06	4.02e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.21e-06	4e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PIK3R1—hematologic cancer	2.2e-06	3.98e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NQO1—hematologic cancer	2.16e-06	3.91e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CD44—hematologic cancer	2.16e-06	3.91e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.15e-06	3.89e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.15e-06	3.89e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.15e-06	3.89e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—CREBBP—hematologic cancer	2.13e-06	3.85e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.05e-06	3.7e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CYCS—hematologic cancer	2.05e-06	3.7e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.03e-06	3.68e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PIK3CB—hematologic cancer	2.03e-06	3.67e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PIK3CD—hematologic cancer	2.02e-06	3.65e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PIK3CG—hematologic cancer	2e-06	3.62e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—ALB—hematologic cancer	1.99e-06	3.6e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.96e-06	3.54e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PIK3R1—hematologic cancer	1.9e-06	3.45e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.9e-06	3.44e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—CREBBP—hematologic cancer	1.9e-06	3.43e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.87e-06	3.38e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—CREBBP—hematologic cancer	1.85e-06	3.35e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.8e-06	3.26e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.8e-06	3.26e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—ALB—hematologic cancer	1.78e-06	3.21e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.76e-06	3.18e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.76e-06	3.18e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PTEN—hematologic cancer	1.75e-06	3.17e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—ALB—hematologic cancer	1.73e-06	3.14e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.73e-06	3.13e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—PIK3CA—hematologic cancer	1.73e-06	3.12e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.71e-06	3.09e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.7e-06	3.08e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.67e-06	3.03e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—EP300—hematologic cancer	1.67e-06	3.03e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.66e-06	3e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.66e-06	3e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.66e-06	3e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.64e-06	2.97e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—ALB—hematologic cancer	1.62e-06	2.93e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.6e-06	2.89e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.57e-06	2.84e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.55e-06	2.8e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.53e-06	2.77e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PTEN—hematologic cancer	1.52e-06	2.75e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.48e-06	2.68e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.47e-06	2.65e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—EP300—hematologic cancer	1.45e-06	2.62e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.43e-06	2.59e-05	CbGpPWpGaD
Apixaban—ABCG2—Metabolism—AKT1—hematologic cancer	1.41e-06	2.55e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.4e-06	2.54e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—ALB—hematologic cancer	1.38e-06	2.5e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PTEN—hematologic cancer	1.36e-06	2.45e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.32e-06	2.4e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PTEN—hematologic cancer	1.32e-06	2.39e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—EP300—hematologic cancer	1.29e-06	2.34e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—EP300—hematologic cancer	1.26e-06	2.28e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.24e-06	2.24e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PTEN—hematologic cancer	1.24e-06	2.24e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.23e-06	2.23e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.22e-06	2.21e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—EP300—hematologic cancer	1.18e-06	2.13e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.14e-06	2.07e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.08e-06	1.96e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.07e-06	1.94e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—ALB—hematologic cancer	1.07e-06	1.93e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PTEN—hematologic cancer	1.06e-06	1.91e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.02e-06	1.85e-05	CbGpPWpGaD
Apixaban—CYP3A5—Metabolism—AKT1—hematologic cancer	1.01e-06	1.83e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—EP300—hematologic cancer	1.01e-06	1.82e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—PIK3CA—hematologic cancer	9.56e-07	1.73e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3CB—hematologic cancer	9.43e-07	1.71e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—PIK3CA—hematologic cancer	9.33e-07	1.69e-05	CbGpPWpGaD
Apixaban—CYP2C8—Metabolism—AKT1—hematologic cancer	8.75e-07	1.58e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—PIK3CA—hematologic cancer	8.72e-07	1.58e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PTEN—hematologic cancer	8.15e-07	1.47e-05	CbGpPWpGaD
Apixaban—CYP2C19—Metabolism—AKT1—hematologic cancer	7.81e-07	1.41e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—EP300—hematologic cancer	7.77e-07	1.41e-05	CbGpPWpGaD
Apixaban—ABCB1—Metabolism—AKT1—hematologic cancer	7.62e-07	1.38e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—PIK3CA—hematologic cancer	7.45e-07	1.35e-05	CbGpPWpGaD
Apixaban—CYP2C9—Metabolism—AKT1—hematologic cancer	7.12e-07	1.29e-05	CbGpPWpGaD
Apixaban—CYP1A2—Metabolism—AKT1—hematologic cancer	6.09e-07	1.1e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—PIK3CA—hematologic cancer	5.75e-07	1.04e-05	CbGpPWpGaD
Apixaban—CYP3A4—Metabolism—AKT1—hematologic cancer	4.7e-07	8.5e-06	CbGpPWpGaD
